September 26, 2023 Sophia Vida
Breaking News

BioStem Receives IRB Approval for Clinical Study to Evaluate Vendaje® in Diabetic Foot Ulcers

POMPANO BEACH, FLORIDA, September 26, 2023 – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, announced today  the approval of an Investigational Review Board (IRB) sanctioned clinical study. This study aims to investigate the utilization and effects of … Continue reading “BioStem Receives IRB Approval for Clinical Study to Evaluate Vendaje® in Diabetic Foot Ulcers”

Breaking News

AURI Announces New CEO

DALLAS, TX, September 25, 2023 – Auri Inc. (OTC PINK: AURI) (“AURI”) (the “Company”) is proud to…

September 25, 2023 Sophia Vida